Health Condition 1: B998- Other infectious disease
Conditions
Interventions
Control Intervention1: NIL: NIL
Sponsors
InBios International Inc
Eligibility
Inclusion criteria
Inclusion criteria: At least 5 years of age. Subject able to give written informed consent/assent as appropriate. Present with at least one of the following symptoms of melioidosis: Sepsis with unknown cause at the time of study enrollment, or Suspected cases of melioidosis by physician with a wide range of symptoms including: Type 2 diabetes with ulceration and abscesses and/or unhealed wounds; Swelling, open wounds/skin abrasions with pus; Multiple abscesses in kidneys, liver, spleen, prostate; Respiratory tract symptoms (sore throat, shortness of breath, pneumonia, cough); Fever with chills and other signs and symptoms consistent with melioidosis; Headache and other signs and symptoms consistent with melioidosis; Muscle soreness and other signs and symptoms consistent with melioidosis; Weight loss and other signs and symptoms consistent with melioidosis.
Exclusion criteria
Exclusion criteria: Currently taking or have taken ceftazidime or meropenem targeting B. pseudomallei in the last 48 hours. Previous enrollment in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate and marketised a noble diagnostic tool for one of the infectious disease like MelioidosisTimepoint: One day for each subject for AMD testing, and up to 6 days longer for collection of additional specimens for a second reference test | — |
Secondary
| Measure | Time frame |
|---|---|
| Active Melioidosis Detect Rapid test will help to diagnose patients with melioidosis within short period of timeTimepoint: One day for each subject for AMD testing, and up to 6 days longer for collection of additional specimens for a second reference test | — |
Countries
India
Contacts
Public ContactSoumi Chowdhury
Kasturba Medical College
Outcome results
None listed